1. Role of Lateral Hypothalamic Orexin (Hypocretin) Neurons in Alcohol Use and Abuse: Recent Advances

   • Leigh C. Walker
   • Sarah Sulaiman Ch’ng
   • Andrew J. Lawrence

   Neuropharmacology (G Aston-Jones, Section Editor) 31 August 2016 Pages: 241 - 252

   

2. New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson’s Disease

   • Michael A. Kelberman
   • Elena M. Vazey

   Neuropharmacology (G Aston-Jones, Section Editor) 28 September 2016 Pages: 253 - 261

3. Pharmacology of the Bed Nucleus of the Stria Terminalis

   • Christelle Glangetas
   • François Georges

   Neuropharmacology (G Aston-Jones, Section Editor) 09 November 2016 Pages: 262 - 270

4. Chelators in Iron and Copper Toxicity

   • Michael K. Lawson
   • Marian Valko
   • Klaudia Jomová

   Chemical and Molecular Toxicology (J Bolton, Section Editor) 03 October 2016 Pages: 271 - 280

   

5. Therapeutic Potential and Mechanisms of Berberine in Cardiovascular Disease

   • Ming Zhang
   • Linjing Feng
   • Li Chen

   Cardiovascular Pharmacology (J Li, Section Editor) 15 September 2016 Pages: 281 - 292

   

6. Metabolomics in Cancer Biomarker Research

   • Xiaoyan Wang
   • Shaoqiu Chen
   • Wei Jia

   Pharmacometabolomics and Toxicometabolomics (C Chen, Section Editor) 11 November 2016 Pages: 293 - 298

7. Enzyme/Prodrug Systems for Cancer Gene Therapy

   • Obeid M. Malekshah
   • Xuguang Chen
   • Arash Hatefi

   Drug Delivery (A Hatefi, Section Editor) 19 October 2016 Pages: 299 - 308

   

8. Challenges in the Delivery of Therapies to Melanoma Brain Metastases

   • Gautham Gampa
   • Shruthi Vaidhyanathan
   • William F. Elmquist

   Molecular Drug Disposition (M Hu, Section Editor) 09 November 2016 Pages: 309 - 325

   

9. Challenges and Opportunities with Predicting In Vivo Phase II Metabolism via Glucuronidation From In Vitro Data

   • Shufan Ge
   • Yifan Tu
   • Ming Hu

   Molecular Drug Disposition (M Hu, Section Editor) 08 November 2016 Pages: 326 - 338

   

10. The Role of Interaction Model in Simulation of Drug Interactions and QT Prolongation

    • Barbara Wiśniowska
    • Sebastian Polak

    Pharmacometrics (H Kimko, Section Editor) Open access 27 October 2016 Pages: 339 - 344